Evaluating Nelipepimut-S in the Treatment of Breast Cancer: A Short Report on the Emerging Data

Por Dillon, Patrick M, Brenin, Christiana M, Slingluff, Craig L
Publicado no Breast Cancer (Dove Med Press) (2020)

CONCORD biomarker prediction for novel drug introduction to different cancer types

Por Kim, Youngchul, Dillon, Patrick M., Park, Taesung, Lee, Jae K.
Publicado no Oncotarget (2017)

Adenoid cystic carcinoma: A review of recent advances, molecular targets, and clinical trials

Por Dillon, Patrick M., Chakraborty, Samhita, Moskaluk, Christopher A., Joshi, Prashant J., Thomas, Christopher Y.
Publicado no Head Neck (2015)

A Mechanistic Study of the Effect of Doxorubicin/Adriamycin on the Estrogen Response in a Breast Cancer Model

Por Pritchard, Jessica E., Dillon, Patrick M., Conaway, Mark R., Silva, Corinne M., Parsons, Sarah J.
Publicado em 2012

Longitudinal patterns of cancer patient reported outcomes in end of life care predict survival

Por Stukenborg, George J., Blackhall, Leslie J., Harrison, James H., Dillon, Patrick M., Read, Paul W.
Publicado no Support Care Cancer (2015)

Anti-Yo Mediated Paraneoplastic Cerebellar Degeneration Associated with Pseudobulbar Affect in a Patient with Breast Cancer

Por Martin, Allison N., Dillon, Patrick M., Jones, David E., Brenin, David R., Lapides, David A.
Publicado no Case Rep Oncol Med (2017)

Efficient dose-finding for drug combination studies involving a shift in study populations

Por Wages, Nolan A., Millard, Trish A., Dillon, Patrick M., Brenin, Christiana M., Petroni, Gina R.
Publicado no Contemp Clin Trials Commun (2020)

A multi-epitope melanoma helper peptide vaccine durably increases Th1 cytokine production by responding lymphocytes

Por Dillon, Patrick M, Olson, Walter C, Czarkowski, Andrea, Petroni, Gina R, Smolkin, Mark, Grosh, William W, Chianese-Bullock, Kimberly A, Deacon, Donna H, Slingluff, Craig L
Publicado em 2013

A melanoma helper peptide vaccine increases Th1 cytokine production by leukocytes in peripheral blood and immunized lymph nodes

Por Dillon, Patrick M, Olson, Walter C, Czarkowski, Andrea, Petroni, Gina R, Smolkin, Mark, Grosh, William W, Chianese-Bullock, Kimberly A, Deacon, Donna H, Slingluff, Craig L
Publicado em 2014

A Phase II study of Dovitinib in Patients With Recurrent or Metastatic Adenoid Cystic Carcinoma

Por Dillon, Patrick M., Petroni, Gina R., Horton, Bethany J., Moskaluk, Christopher A., Fracasso, Paula M., Douvas, Michael G, Varhegyi, Nikole, Zaja-Milatovic, Snjezana, Thomas, Christopher Y.
Publicado no Clin Cancer Res (2017)

Early Palliative Care Reduces End‐of‐Life Intensive Care Unit (ICU) Use but Not ICU Course in Patients with Advanced Cancer

Por Romano, Andrew M., Gade, Kristine E., Nielsen, Gradon, Havard, Robert, Harrison, James H., Barclay, Josh, Stukenborg, George J., Read, Paul W., Blackhall, Leslie J., Dillon, Patrick M.
Publicado no Oncologist (2017)

Genetically Engineered Cancer Models, But Not Xenografts, Faithfully Predict Anticancer Drug Exposure in Melanoma Tumors

Por Combest, Austin J., Roberts, Patrick J., Dillon, Patrick M., Sandison, Katie, Hanna, Suzan K., Ross, Charlene, Habibi, Sohrab, Zamboni, Beth, Müller, Markus, Brunner, Martin, Sharpless, Norman E., Zamboni, William C.
Publicado em 2012

A pilot study of the immunogenicity of a 9-peptide breast cancer vaccine plus poly-ICLC in early stage breast cancer

Por Dillon, Patrick M., Petroni, Gina R., Smolkin, Mark E., Brenin, David R., Chianese-Bullock, Kimberly A., Smith, Kelly T., Olson, Walter C., Fanous, Ibrahim S., Nail, Carmel J., Brenin, Christiana M., Hall, Emily H., Slingluff, Craig L.
Publicado no J Immunother Cancer (2017)

Combined PI3K/mTOR and MEK Inhibition Provides Broad Antitumor Activity in Faithful Murine Cancer Models

Por Roberts, Patrick J., Usary, Jerry E., Darr, David B., Dillon, Patrick M., Pfefferle, Adam D., Whittle, Martin C., Duncan, James S., Johnson, Soren M., Combest, Austin J., Jin, Jian, Zamboni, William C., Johnson, Gary L., Perou, Charles M., Sharpless, Norman E.
Publicado em 2012

Association of Incident Amelanotic Melanoma with Phenotypic Characteristics, MC1R Status, and Prior Amelanotic Melanoma

Por Vernali, Steven, Waxweiler, Weston T., Dillon, Patrick M., Kanetsky, Peter A., Orlow, Irene, Luo, Li, Busam, Klaus J., Kricker, Anne, Armstrong, Bruce K., Anton-Culver, Hoda, Gruber, Stephen B., Gallagher, Richard P., Zanetti, Roberto, Rosso, Stefano, Sacchetto, Lidia, Dwyer, Terence, Cust, Anne E., Ollila, David W., Begg, Colin B., Berwick, Marianne, Thomas, Nancy E.
Publicado no JAMA Dermatol (2017)

Comparison of Clinicopathologic Features and Survival of Histopathologically Amelanotic and Pigmented Melanomas: A Population-Based Study

Por Thomas, Nancy E., Kricker, Anne, Waxweiler, Weston T., Dillon, Patrick M., Busam, Klaus J., From, Lynn, Groben, Pamela A., Armstrong, Bruce K., Anton-Culver, Hoda, Gruber, Stephen B., Marrett, Loraine D., Gallagher, Richard P., Zanetti, Roberto, Rosso, Stefano, Dwyer, Terence, Venn, Alison, Kanetsky, Peter A., Orlow, Drs. Irene, Paine, Susan, Ollila, David W., Reiner, Anne S., Luo, Li, Hao, Honglin, Frank, Jill S., Begg, Colin B., Berwick, Marianne
Publicado no JAMA Dermatol (2014)

A randomized phase II neoadjuvant study of cisplatin, paclitaxel with or without everolimus in patients with stage II/III triple-negative breast cancer (TNBC): Responses and long-t...

Por Jovanović, Bojana, Mayer, Ingrid A., Mayer, Erica L., Abramson, Vandana G., Bardia, Aditya, Sanders, Melinda E., Kuba, M. Gabriela, Estrada, Monica V., Beeler, J. Scott, Shaver, Timothy M., Johnson, Kimberly C., Sanchez, Violeta, Rosenbluth, Jennifer M., Dillon, Patrick M., Forero-Torres, Andres, Chang, Jenny C., Meszoely, Ingrid M., Grau, Ana M., Lehmann, Brian D., Shyr, Yu, Sheng, Quanhu, Chen, Sheau-Chiann, Arteaga, Carlos L., Pietenpol, Jennifer A.
Publicado no Clin Cancer Res (2017)